Literature DB >> 9825787

The rate of CD4 decline as a determinant of progression to AIDS independent of the most recent CD4 count. The Italian Seroconversion Study.

A Cozzi Lepri1, C A Sabin, A N Phillips, C A Lee, P Pezzotti, G Rezza.   

Abstract

The data of two cohort studies of HIV-infected individuals were used to examine whether the rate of CD4 decline is a determinant of HIV progression, independent of the most recent CD4 count. Time from seroconversion to clinical AIDS was the main outcome measure. Rates of CD4 decline were estimated using the ordinary least squares regression method. AIDS incidences were compared in individuals who had previously experienced either a steeper or a less steep rate of CD4 decline. Cox proportional hazards model including a time-dependent covariate for the rate of CD4 decline was performed. The rate of prior CD4 decline was significantly associated with the risk of developing AIDS independently from the most recent CD4 count, with a 2% increase in hazard of AIDS (P < 0.01) for a difference of 10 cells/mm3 in the estimated yearly drop in CD4 count. This finding gives scientific credit to the belief that individuals with a prior steeper CD4 decline consistently have a higher subsequent risk of developing AIDS than those with a less steep prior decline.

Entities:  

Mesh:

Year:  1998        PMID: 9825787      PMCID: PMC2809533          DOI: 10.1017/s095026889800140x

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  7 in total

1.  Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies.

Authors:  Marcel Wolbers; Abdel Babiker; Caroline Sabin; Jim Young; Maria Dorrucci; Geneviève Chêne; Cristina Mussini; Kholoud Porter; Heiner C Bucher
Journal:  PLoS Med       Date:  2010-02-23       Impact factor: 11.069

2.  CD4(+) T cell count decreases by ethnicity among untreated patients with HIV infection in South Africa and Switzerland.

Authors:  Margaret May; Robin Wood; Landon Myer; Patrick Taffé; Andri Rauch; Manuel Battegay; Matthias Egger
Journal:  J Infect Dis       Date:  2009-12-01       Impact factor: 5.226

3.  Population-based biochemistry, immunologic and hematological reference values for adolescents and young adults in a rural population in Western Kenya.

Authors:  Clement Zeh; Pauli N Amornkul; Seth Inzaule; Pascale Ondoa; Boaz Oyaro; Dufton M Mwaengo; Hilde Vandenhoudt; Anthony Gichangi; John Williamson; Timothy Thomas; Kevin M Decock; Clyde Hart; John Nkengasong; Kayla Laserson
Journal:  PLoS One       Date:  2011-06-21       Impact factor: 3.240

4.  Limited durability of viral control following treated acute HIV infection.

Authors:  Daniel E Kaufmann; Mathias Lichterfeld; Marcus Altfeld; Marylyn M Addo; Mary N Johnston; Paul K Lee; Bradford S Wagner; Elizabeth T Kalife; Daryld Strick; Eric S Rosenberg; Bruce D Walker
Journal:  PLoS Med       Date:  2004-10-26       Impact factor: 11.069

5.  Factors Associated with Timing of Initiation of Antiretroviral Therapy among HIV-1 Infected Adults in the Niger Delta Region of Nigeria.

Authors:  Dimie Ogoina; Finomo Finomo; Tubonye Harry; Otonyo Inatimi; Ikenna Ebuenyi; Wolo-wolo Tariladei; Abimbola Anne Afolayan
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

6.  Evident stabilization of the clinical profile in HIV/AIDS as evaluated in an open label clinical trial using a polyherbal formulation.

Authors:  Mangaiarkarasi Asokan; Imtiaz Nisar Lone; Anil Babu Mukthey; Paul Siddhartha; Gayathri Mariappa; Praveen Kumar Kotehal; Bhuthiah Satish; Eugene Wilson; Savariraj Sahayam; Gopinath Velayutham; Rajalakshmi Perumal; Karthikeyan Baskaran; Devanathan Rengarajan; Ravichandran Muthusamy; Mariamma Philip; K C Ravindra; Jeelan N Basha; Pushpak Mizar; Gurvinder Kaur; Narinder K Mehra; Tapas K Kundu; D K Subbakrishna; Kadappa Shivappa Satish; Udaykumar Ranga
Journal:  Indian J Med Res       Date:  2013-06       Impact factor: 2.375

7.  Host HLA B*allele-associated multi-clade Gag T-cell recognition correlates with slow HIV-1 disease progression in antiretroviral therapy-naïve Ugandans.

Authors:  Jennifer Serwanga; Leigh Anne Shafer; Edward Pimego; Betty Auma; Christine Watera; Samantha Rowland; David Yirrell; Pietro Pala; Heiner Grosskurth; Jimmy Whitworth; Frances Gotch; Pontiano Kaleebu
Journal:  PLoS One       Date:  2009-01-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.